Surrogate End Points of Antihypertensive Treatment: Left Ventricular Hypertrophy and Structural Alteration of Carotid Arteries

Publisher： Karger

E-ISSN： 1424-0556|1|2|89-95

ISSN： 1422-9528

Source： Heart Drug, Vol.1, Iss.2, 2004-11, pp. : 89-95

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Left Ventricular Hypertrophy in Hypertension

By  

Heart Drug, Vol. 2, Iss. 5, 2003-01 ,pp. : 251-265

Karger

Access to resources Recommend Favorite

Left Ventricular Hypertrophy in Hypertension

By  

Heart Drug, Vol. 2, Iss. 3, 2002-07 ,pp. : 142-156

Karger

Access to resources Recommend Favorite

Aggressive antihypertensive regimens can reduce left ventricular hypertrophy and improve arterial compliance

By  

Inpharma, Vol. 1, Iss. 1562, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Left Ventricular Hypertrophy: A Shift in Paradigm

By  

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 157-171

Bentham Science Publishers

Access to resources Recommend Favorite

Losartan/Hydrochlorothiazide: A Review of its Use in the Treatment of Hypertension and for Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1239-1265

Adis International

Access to resources Recommend Favorite